Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy
Source: SeekingAlpha
2026-01-22 07:34:46 ET
On December 4, 2025, I initiated coverage of Kura Oncology (KURA) in this article with a Speculative Buy rating....
Read the full article on Seeking Alpha
For further details see:
Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy
Kura Oncology Inc.
NASDAQ: KURA
KURA Trading
2.09% G/L:
$8.79 Last:
63,058 Volume:
$8.67 Open:
KURA Latest News
March 06, 2026 07:30:00 am
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2026 06:31:00 am
Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 07:30:00 am
Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results
KURA Stock Data
$684,827,867
74,138,925
1.16%
63
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
